Foresee Pharmaceuticals (Taiwan) Insiders
6576 Stock | TWD 73.70 0.10 0.14% |
Foresee Pharmaceuticals employs about 29 people. The company is managed by 23 executives with a total tenure of roughly 143 years, averaging almost 6.0 years of service per executive, having 1.26 employees per reported executive. Recap of Foresee Pharmaceuticals' management performance can provide insight into the venture performance.
Benjamin Chien Chairman Chairman of the Board, Acting General Manager, Chief Strategy Officer |
Foresee |
Foresee Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.1768) % which means that it has lost $0.1768 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3539) %, meaning that it generated substantial loss on money invested by shareholders. Foresee Pharmaceuticals' management efficiency ratios could be used to measure how well Foresee Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Foresee Pharmaceuticals Workforce Comparison
Foresee Pharmaceuticals Co is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 241. Foresee Pharmaceuticals retains roughly 29.0 in number of employees claiming about 12% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (1.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.57. Foresee Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Foresee Pharmaceuticals Price Series Summation is a cross summation of Foresee Pharmaceuticals price series and its benchmark/peer.
Foresee Pharmaceuticals Notable Stakeholders
A Foresee Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Foresee Pharmaceuticals often face trade-offs trying to please all of them. Foresee Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Foresee Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Benjamin Chien | Chairman of the Board, Acting General Manager, Chief Strategy Officer | Profile | |
Max Chan | Chief Financial Officer, Head of Finance | Profile | |
Sheila Chuang | Accounting Mang | Profile | |
Mathieu Boudreau | Deputy General Manager-Business Development | Profile | |
MengKung Chan | Chief Officer | Profile | |
John Mao | Senior Deputy General Manager | Profile | |
Liangshang Gan | General Manager | Profile | |
David Lau | Senior Deputy General Manager-NCE Preclinical and Clinical Development | Profile | |
Vincent Yen | Director | Profile | |
Sonia Wu | Director | Profile | |
JiaLong Lee | Director | Profile | |
Kunhong Lai | Independent Director | Profile | |
Yuhua Li | Deputy General Manager-RD Pipeline | Profile | |
FuShiow Yin | Independent Director | Profile | |
Hank Lai | Independent Director | Profile | |
Wenjin Yang | Chief Scientific Officer, Deputy General Manager | Profile | |
Jagdish Parasrampuria | Senior Deputy General Manager-Drug Product | Profile | |
WenChi Lee | Independent Director | Profile | |
Peifen Chou | Consultant | Profile | |
Ronald Dadino | Senior Deputy General Manager-Pharmaceutical Manufacturing | Profile | |
Yisheng Lee | Chief Medical Officer, Director | Profile | |
Jeff Wang | Director | Profile | |
Digger Chen | General Counsel, Deputy General Manager | Profile |
About Foresee Pharmaceuticals Management Performance
The success or failure of an entity such as Foresee Pharmaceuticals often depends on how effective the management is. Foresee Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Foresee management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Foresee management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan. FORESEE PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in Foresee Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Foresee Pharmaceuticals Co. Check Foresee Pharmaceuticals' Beneish M Score to see the likelihood of Foresee Pharmaceuticals' management manipulating its earnings.
Foresee Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Foresee Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Foresee Pharmaceuticals within its industry.Foresee Pharmaceuticals Manpower Efficiency
Return on Foresee Pharmaceuticals Manpower
Revenue Per Employee | 7.8M | |
Revenue Per Executive | 9.8M | |
Net Loss Per Employee | 19.6M | |
Net Loss Per Executive | 24.8M |
Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.